Tech

Dubious $56, 000 Alzheimer’s drug spurs largest Medicare price hike ever

Enlarge / Biogen Inc. headquarters in Cambridge, Massachusetts. Biogen Inc. shares soared after its controversial Alzheimer’s disease therapy was approved by US regulators. (credit: Getty | Bloomberg ) Seniors throughout the US will see a hefty increase to their health care premiums next year thanks in large part to Biogen’s Alzheimer’s drug, Aduhelm, which is […]

Business

Why the FDA’s ruling on mixing and matching vaccines will help more people get boosters

The FDA permitting a mix-and-match vaccine booster approach increases access in three key ways: it allows people to get any booster that’s readily available to them, lets them choose which one they get, and reduces uncertainty about safety and efficacy. Read More